Detection and treatment of early stage prostate cancer. Seminar. USA, 1993/12.
We examine changes in the detection and treatment of prostate cancer from the perspective of the urologist.
There has been an extraordinary increase in the incidence of prostate cancer (60% from 1990 to 1993).
We calculated, based on data from the literature and assumptions about changes in urological practice, that 52% of newly diagnosed cases would be treated by radical prostatectomy in 1993.
Extrapolating from the work of Catalona, we derived the number of office consultations, prostate biopsies and orchiectomies associated with the diagnosis and treatment of these tumors.
Applying Health Care Financing Administration reimbursements to our figures, we calculated that each urologist would realize $45,370 for prostate cancer care in the Medicare population in 1993.
Mots-clés Pascal : Epithélioma, Prostate, Spécialité médicale, Urologie, Prostatectomie, Antigène spécifique tumeur, Etats Unis, Amérique du Nord, Amérique, Diagnostic, Traitement, Homme, Mâle, Appareil urinaire pathologie, Prostate pathologie, Appareil génital mâle pathologie, Tumeur maligne, Chirurgie, Exploration immunologique
Mots-clés Pascal anglais : Carcinoma, Prostate, Medical specialty, Urology, Prostatectomy, Tumor specific antigen, United States, North America, America, Diagnosis, Treatment, Human, Male, Urinary system disease, Prostate disease, Male genital diseases, Malignant tumor, Surgery, Immunological investigation
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0217761
Code Inist : 002B14D02. Création : 09/06/1995.